Management of substance use disorder in schizophrenia patients: current guidelines.
Substance use disorder is the most frequent and clinically significant comorbidity among schizophrenia patients today. All schizophrenia patients should be assessed and monitored carefully regarding their substance use. Those with any regular use of alcohol or other drugs should be considered at risk for multiple adverse effects. As therapies for co-occurring substance use disorders have evolved over the past 20 years, medication management, psychosocial interventions, and rehabilitation models have increasingly emphasized the integration of mental health and substance abuse treatments, attention to group and residential interventions, matching interventions to stage of treatment, comprehensiveness, and long-term perspectives on recovery. Clinicians should understand the implications of each of these principles of care.
Drake
Robert E
RE
Department of Psychiatry, Dartmouth Medical School, Lebanon, New Hampshire 03766, USA. Robert.E.Drake@dartmouth.edu
D014150:Antipsychotic Agents / Q000627:therapeutic use; D006801:Humans; D012559:Schizophrenia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000150:complications* / Q000175:diagnosis
D014150:Antipsychotic Agents